Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Nerea Vega-Garcia
889  Ergebnisse:
Personensuche X
?
1

PB1700: GENOMIC CHARACTERIZATION OF CHILDHOOD B-OTHER ACUTE..:

Garcés, Clara Vicente ; Fernández, Guerau ; Cebollada, Elena Esperanza...
HemaSphere.  7 (2023)  S3 - p. e51978b7 , 2023
Link: https://doi.org/10.1097/..
 
?
2

A human genome editing–based MLL::AF4 ALL model recapitulat..:

Bueno, Clara ; Torres-Ruiz, Raul ; Velasco-Hernandez, Talia...
Blood.  142 (2023)  20 - p. 1752-1756 , 2023
Link: https://doi.org/10.1182/..
 
?
3

Fusion InPipe, an integrative pipeline for gene fusion dete..:

Vicente-Garcés, Clara ; Maynou, Joan ; Fernández, Guerau...
Frontiers in Molecular Biosciences.  10 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
4

The relapsed acute lymphoblastic leukemia network (ReALLNet..:

Velasco, Pablo ; Bautista, Francisco ; Rubio, Alba...
Frontiers in Pediatrics.  11 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
5

A human genome editing-based MLL-AF4 acute lymphoblastic le..:

Clara Bueno ; Raul Torres-Ruíz ; Oscar Molina...
doi:10.5281/zenodo.7729079.  , 2023
Link: https://zenodo.org/recor..
 
?
6

DataSheet1_Fusion InPipe, an integrative pipeline for gene ..:

Clara Vicente-Garcés ; Joan Maynou ; Guerau Fernández...
doi:10.3389/fmolb.2023.1141310.s001.  , 2023
Link: https://doi.org/10.3389/..
 
?
7

Fusion InPipe, an integrative pipeline for gene fusion dete..:

Clara Vicente-Garcés ; Joan Maynou ; Guerau Fernández...
https://www.frontiersin.org/articles/10.3389/fmolb.2023.1141310/full.  , 2023
Link: https://doi.org/10.3389/..
 
?
8

The relapsed acute lymphoblastic leukemia network (ReALLNet..:

Pablo Velasco ; Francisco Bautista ; Alba Rubio...
https://www.frontiersin.org/articles/10.3389/fped.2023.1269560/full.  , 2023
Link: https://doi.org/10.3389/..
 
?
9

CD34+CD19−CD22+ B-cell progenitors may underlie phenotypic ..:

Bueno, Clara ; Barrera, Susana ; Bataller, Alex...
Blood.  140 (2022)  1 - p. 38-44 , 2022
Link: https://doi.org/10.1182/..
 
?
10

Technical Validation and Clinical Utility of an NGS Targete..:

Vicente-Garcés, Clara ; Esperanza-Cebollada, Elena ; Montesdeoca, Sara...
Frontiers in Molecular Biosciences.  9 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
11

Image1_Technical Validation and Clinical Utility of an NGS ..:

Clara Vicente-Garcés ; Elena Esperanza-Cebollada ; Sara Montesdeoca...
doi:10.3389/fmolb.2022.854098.s002.  , 2022
Link: https://doi.org/10.3389/..
 
?
12

Technical Validation and Clinical Utility of an NGS Targete..:

Clara Vicente-Garcés ; Elena Esperanza-Cebollada ; Sara Montesdeoca...
https://www.frontiersin.org/articles/10.3389/fmolb.2022.854098/full.  , 2022
Link: https://doi.org/10.3389/..
 
?
13

DataSheet1_Technical Validation and Clinical Utility of an ..:

Clara Vicente-Garcés ; Elena Esperanza-Cebollada ; Sara Montesdeoca...
doi:10.3389/fmolb.2022.854098.s001.  , 2022
Link: https://doi.org/10.3389/..
 
?
14

Measurable Residual Disease Assessed by Flow-Cytometry Is a..:

Vega-García, Nerea ; Perez-Jaume, Sara ; Esperanza-Cebollada, Elena...
Frontiers in Pediatrics.  8 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
15

Measurable Residual Disease Assessed by Flow-Cytometry Is a..:

Nerea Vega-García ; Sara Perez-Jaume ; Elena Esperanza-Cebollada...
https://www.frontiersin.org/articles/10.3389/fped.2020.614521/full.  , 2021
Link: https://doi.org/10.3389/..
 
1-15